Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Linde
LIN
|
+$588M |
| 2 |
Apple
AAPL
|
+$574M |
| 3 |
Illumina
ILMN
|
+$398M |
| 4 |
argenx
ARGX
|
+$306M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$250M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$600M |
| 2 |
AbbVie
ABBV
|
+$323M |
| 3 |
Sherwin-Williams
SHW
|
+$309M |
| 4 |
Atlassian
TEAM
|
+$250M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$241M |
Sector Composition
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.43% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Adeia
ADEA
$1.67B
| $406K | ﹤0.01% |
45,814
+24,367
| +114% | +$216K |
|
2127
Liberty Latin America Class C
LILAK
$1.55B
| $405K | ﹤0.01% |
49,047
+18,762
| +62% | +$155K |
|
2128
Astec Industries
ASTE
$1.06B
| $405K | ﹤0.01% |
+9,827
| New | +$405K |
|
2129
Claros Mortgage Trust
CMTG
$538M
| $404K | ﹤0.01% |
34,756
+18,329
| +112% | +$213K |
|
2130
Mesa Laboratories
MLAB
$331M
| $404K | ﹤0.01% |
+2,314
| New | +$404K |
|
2131
Shenandoah Telecom
SHEN
$732M
| $403K | ﹤0.01% |
+21,207
| New | +$403K |
|
|
ATRI
2132
DELISTED
Atrion Corp
ATRI
| $403K | ﹤0.01% |
+637
| New | +$403K |
|
2133
Cassava Sciences
SAVA
$101M
| $402K | ﹤0.01% |
16,690
+9,156
| +122% | +$221K |
|
2134
IMAX
IMAX
$1.67B
| $402K | ﹤0.01% |
+20,968
| New | +$402K |
|
2135
Ecovyst
ECVT
$1.04B
| $402K | ﹤0.01% |
36,398
+18,814
| +107% | +$208K |
|
2136
Fluence Energy
FLNC
$893M
| $402K | ﹤0.01% |
19,854
-31,684
| -61% | -$641K |
|
2137
Avidity Biosciences
RNA
$6.04B
| $401K | ﹤0.01% |
+26,156
| New | +$401K |
|
|
PDM
2138
Piedmont Realty Trust, Inc.
PDM
$1.08B
| $399K | ﹤0.01% |
54,690
+29,520
| +117% | +$215K |
|
|
BBBY
2139
Bed Bath & Beyond, Inc.
BBBY
$611M
| $398K | ﹤0.01% |
+19,635
| New | +$398K |
|
2140
Protagonist Therapeutics
PTGX
$3.59B
| $397K | ﹤0.01% |
+17,250
| New | +$397K |
|
|
STER
2141
DELISTED
Sterling Check Corp. Common Stock
STER
| $397K | ﹤0.01% |
35,617
+19,929
| +127% | +$222K |
|
2142
German American Bancorp
GABC
$1.53B
| $396K | ﹤0.01% |
+11,874
| New | +$396K |
|
2143
Unitil
UTL
$812M
| $396K | ﹤0.01% |
+6,959
| New | +$396K |
|
2144
QCR Holdings
QCRH
$1.32B
| $395K | ﹤0.01% |
8,994
+4,253
| +90% | +$187K |
|
|
ACCD
2145
DELISTED
Accolade, Inc. Common Stock
ACCD
| $395K | ﹤0.01% |
27,455
+14,653
| +114% | +$211K |
|
2146
Usana Health Sciences
USNA
$553M
| $394K | ﹤0.01% |
+6,272
| New | +$394K |
|
2147
SpartanNash
SPTN
$901M
| $394K | ﹤0.01% |
15,902
+8,623
| +118% | +$214K |
|
2148
American Axle
AXL
$706M
| $394K | ﹤0.01% |
50,482
+27,490
| +120% | +$215K |
|
|
TE
2149
T1 Energy Inc.
TE
$288M
| $393K | ﹤0.01% |
44,271
+25,371
| +134% | +$225K |
|
|
SLCA
2150
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $393K | ﹤0.01% |
32,954
+17,869
| +118% | +$213K |
|